×
App Icon
The Standard e-Paper
Read Offline Anywhere
★★★★ - on Play Store
Download Now

Kemri: TB vaccine trials promising, treatment period to reduce

Vocalize Pre-Player Loader

Audio By Vocalize

Tuberculosis remains a leading killer disease in Kenya. [Courtesy]

The Kenya Medical Research Institute (KEMRI) has said that the clinical trials of its Tuberculosis (TB) vaccine for adults and children is promising.

Once the tests are conclusive, KEMRI says it would seek approval from the World Health Organization (WHO) to roll out the vaccine for public use.

Premium Article

Get Full Access for Ksh299/Week.

Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
By AFP 13 hrs ago
Sports
Man City rout Chelsea to close gap on leaders Arsenal
Sports
Inside the 19 counties set to decide Cricket Kenya's new leadership
Sports
Hail the new sheriffs in town: Butere and MGK retain titles as new champions are crowned
Athletics
Kamworor now dreaming big ahead of London Marathon